JYNT,The Joint Corp. | Healthcare

Healthcare

JYNT

All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities

The Joint Corp.JYNT

USD

- At close

USD

- Until the end

The complete list of US stocks

MAX

Overview >

Market Cap

152.54M

Revenue (ttm)

51.90M

Net Income (ttm)

-8.53M

Shares Out

15.32M

EPS (ttm)

-0.57

PE Ratio

n/a

Forward PE

61.08

Dividend

n/a

Ex-Dividend Date

n/a

Volume

n/a

Open

9.95

Previous Close

9.94

Day's Range

9.93 - 10.01

52-Week Range

9.58 - 17.82

Beta

1.46

Analysts

Strong Buy

Price Target

17.50 (+75.79%)

Earnings Date

May 1, 2025

Description >

The Joint Corp. develops, owns, operates, supports, and manages chiropractic clinics.

The company operates in two segments, Corporate Clinics and Franchise Operations. It operates through direct ownership, management arrangements, franchising, and regional developers.

As of March 1, 2022, the company operated approximately 700 locations in the United States. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.

Latest News >

Realty Income Q3 Adjusted FFO, Revenue Increase; 2024 Guidance Narrowed

Nov 4, 2024

04:27 PM EST, 11/04/2024 (MT Newswires) -- Realty Income ( O ) reported Q3 adjusted funds from operations late Monday of $1.05 per diluted share, up from $1.02 a year earlier. Analysts polled by Capital IQ expected $1.06. Revenue for the quarter ended Sept. 30 was $1.33 billion, up from $1.04 billion a year earlier. Analysts surveyed by Capital IQ...

GoodRx, PBMs accused of suppressing reimbursements to independent pharmacies

Nov 4, 2024

Nov 4 (Reuters) - Drug coupon aggregator GoodRx ( GDRX ) and pharmacy benefit managers including CVS Caremark and Express Scripts have been hit with at least three class action lawsuits accusing them of working together to suppress reimbursements to small pharmacies for generic prescription drugs. The first lawsuit was filed by Minnesota-based Keaveny Drug in federal court in Los...

AvalonBay Communities Q3 Core FFO Rises; Q4 Outlook Set, 2024 Guidance Updated

Nov 4, 2024

04:33 PM EST, 11/04/2024 (MT Newswires) -- AvalonBay Communities ( AVB ) reported Q3 core funds from operations late Monday of $2.74 per diluted share, up from $2.66 a year earlier. Analysts surveyed by Capital IQ expected $2.72. The company expects Q4 core funds from operations of $2.78 to $2.88 a share. Analysts surveyed by Capital IQ expect $2.83. AvalonBay...

Aspen Technology Fiscal Q1 Non-GAAP Earnings, Revenue Fall; Shares Down After Hours

Nov 4, 2024

04:33 PM EST, 11/04/2024 (MT Newswires) -- Aspen Technology ( AZPN ) reported fiscal Q1 non-GAAP earnings late Monday of $0.85 per diluted share, down from $1.16 a year earlier. Analysts polled by Capital IQ expected $1.53. Revenue for the quarter ended Sept. 30 was $215.9 million, compared with $249.3 million a year earlier. Analysts polled by Capital IQ expected...